As we rang in 2014, articles focusing on former President Bush’s angioplasty and the potential overuse of stents had subsided and in its place we saw a surge in news focused on the increased use of new technologies in interventional cardiology. Now that we are well into 2014, we have collected some highlights of the hottest news in interventional cardiology thus far.
Hot topics this year include safety concerns in the cath lab, approval and improvements of new techniques, as well as a look into what is next for this industry.
Radiation Exposure – We continue to see this as an increasing issue among interventional cardiologists. Radiation exposure in the cath lab has been linked to head and neck tumors among other medical issues. The use of the lead aprons, while trying to reduce the amount of radiation exposure, also puts strain on the physicians.
- Climbing Head and Neck Tumor Count in Interventional Cardiologists Prompts Calls for More Study
- Fifty Shades of Gy: An Explicit Look at Occupational Radiation Safety
The failure of the Symplicity Renal Denervation Trial – As new technologies are developed, they are tested and in some cases shown to not work as well as we hoped. It will be interesting to see what developments in renal denervation will come of this in the future.
FDA approval of CoreValve – An exciting new advancement for interventional cardiology in 2014 was the FDA approval of the CoreValve. The CoreValve was developed to serve patients with severe aortic stenosis and received FDA approval shortly after a successful clinical trial.
Stenting in the news – As previously mentioned, advancements in technology brings with it new ways of doing “old” procedures. This year, we have been introduced to a bioresorbable stent. The patients that received this stent showed angiographic results similar to those of permanent metal stents and could mean a new wave of stent technology.
Transradial access – There has been much discussion around the benefits and adoption of transradial access as it becomes more common in the United States. The article below is a round table focusing on radial vs femoral artery access in patients.
Transcatheter aortic valve replacement (TAVR) – TAVR has been a hot topic in interventional cardiology over the last few years as more hospitals adopt this technique for structural heart repair. For the first time, 2014 marks a new set of guidelines for treating patient with valvular heart disease.
Looking ahead – With a procedure, such as PCI, which has remained relatively unchanged for decades, there is bound to be changes as our technology advances.
We look forward to seeing what news is to come for the remainder of 2014. Be sure to check back at the end of the year for a recap of Interventional Cardiology news in 2014, and regular updates from Corindus.